ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Marksans Pharma Ltd reported revenue from operations of ₹940.2 Cr (+30.5% YoY) and net profit of ₹143.5 Cr (+44.8% YoY) for Q2 FY27.
Marksans Pharma Ltd reported revenue from operations of ₹840.8 Cr (+35.6% YoY) and net profit of ₹159.4 Cr (+173.9% YoY) for Q1 FY27.
Marksans Pharma Ltd reported revenue from operations of ₹856.1 Cr (+20.8% YoY) and net profit of ₹149 Cr (+64.3% YoY) for Q4 FY26.
Marksans Pharma reported audited FY26 financial results and recommended a ₹0.90 per share dividend. Consolidated annual revenue reached ₹2,950.94 Crore, reflecting strong operational growth.